1.    Reduction of time taken to analyze and develop a product. It took more than 8 years to develop a new product and bring the drug and medicine to the market, which was reduced by the CRO.

2.    With the increase in complexity of the clinical trials, the CRO showed much higher performance output.

3.    With the increase in the clinical trial results and its complexity also, the research organization was able to handle and manipulate the data results well.

4.    Outsourcing to particular CRO in a region can help in identification of regionalized diseases and the market development on that region.

5.    When there are less service-in houses or unavailability of service-in houses, CRO helps the company to perform the routine work without interruption.

6.    To develop a drug, the companies required large amount of patient records, which was very difficult to collect and was the reason for the drag in time to develop a new product. With the CRO in market, they were able to collect huge amount of records needed and process collected data much faster thereby reducing the time in developing a newer product into the market.

7.    The company had no knowledge of affairs within a particular country. For example: some countries required the presence of medicine flow throughout the year due to certain problems, while some countries require medicinal aid only during calamities. Under such circumstances, the company can focus on countries that require aid in hand often and have a minimal focus on the countries that require attention less often. This knowledge of regulatory affairs of countries was not available to the companies until the CROs emerged.

8.    Clinical trials cannot be performed with only a single country population in mind, because any problem may arise with change of climate, food, living, and atmosphere. In addition, clinical trials have to perform to population of all age. Therefore, the natures of clinical trials are multi national and multi centered. CROs were performing this well since all data are centrally maintained.

9.    The technical knowledge and technicians within the Contract Research organizations were able to analyze data faster and eliminating the need for the companies to analyze the data themselves, thereby reducing the cost expenses involved.

10.    The sponsors were able to now change and vary the fixed costs previously had to be given to the personnel involving the data analyzing into variable amount, since the CRO performed data analyzing prior to the company. The company met the profit margins.

With the discovery of newer diseases, the need to develop better drugs and antidote arises. Using the Contract Research Organization and their services, the requirements can be met and the need for survival is best achieved. Making healthy future is what everyone dreams of. Why not start encouraging the CROs to give a better head start?

The contract research organizations are individual organizations that conduct a clinical trial. The Organization takes responsibility for the proper communication between sponsors, investigators, physicians and the IET institute board members. They are also responsible for the Data management obtained as the result of the clinical trials. The Clinical Research Associates’ primary job is to monitor the clinical trials. The Contract research organization monitors the clinical trial from phase 1 to phase 4 and provide data results to the CRA’s. While the CRA are responsible to collect the patient’s clinical trial data, the CRO maintains the data results and product study results. With the advent of latest technology, the CRO are able to control the data via intranet centrally.

Outsourcing in Medical Research

Contract research organizations emerged because of outsourcing done by the pharmaceutical companies. Outsourcing has become more and more common on pharmaceutical industry due to increasing pressure, the manufacturing, and marketing of products and the need to compete in the field. As a result, computer integrated manufacturing and marketing of medicines are provided to the consumers. The profit margins for the competitors and the manufacturers were affected due to ‘downsizing’ of the market. Therefore, they had to search for a new option of survival. With the pressure in external and internal cost effects on the company and considering the urge for leading a future market, the pharmaceutical industry started to outsource research projects and clinical trials to the contract research organizations. This approach of outsourcing has resulted in the development of product for the companies and delivery of the products on time to the consumers. The profit margins are also maintained without any bigger loss. With the demand on the market and the increasing cost pressure in the future, the Contract research organizations are better solutions for the pharmaceutical industries and in the field of medical research. It therefore becomes the responsibility of the companies to develop the CRO market and the key players.